Ready-to-administer Calcium Gluconate in non-PVC, non-DEHP containers is designed to promote safety and convenience
LAKE ZURICH - Fresenius Kabi announced Wednesday it has introduced two new presentations of Calcium Gluconate in Sodium Chloride Injection in the United States in the company's proprietary, ready-to-administerfreeflex containers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005262/en/
Ready-to-administer Calcium Gluconate in non-PVC, non-DEHP containers from Fresenius Kabi.
Fresenius Kabi now has the broadest portfolio of Calcium Gluconate Injection products available from any manufacturer in the United States:
"Our new premixed Calcium Gluconatefreeflexofferings will help meet the growing demand for ready-to-administer medicines in the U.S.," said John Ducker, president and CEO of Fresenius Kabi USA. "By offering Calcium Gluconate Injection in two delivery systems, Fresenius Kabi can provide health care professionals with more flexibility and choice to best serve patient needs."